albuterol has been researched along with Tremor in 68 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Sixty-three adolescent and adult asthmatic patients were randomized to receive at separate treatment visits single doses via a pressurized metered-dose inhaler of either placebo/hydrofluoroalkane (HFA) 134a; 100 microg, 200 microg, or 400 microg albuterol/HFA 134a; 100 microg or 200 microg albuterol/chlorofluorocarbon (CFC)." | 9.10 | A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients. ( Batty, EP; Langley, SJ; Masterson, CM; Sykes, AP; Woodcock, A, 2002) |
| " The bronchodilator, cardiovascular, and tremorigenic responses following administration of salbutamol (SAL), terbutaline (TER) and fenoterol (FEN) by closed-port intermittent nebulization were compared for a period of 8 hr." | 9.08 | Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. ( Naspitz, CK; Scalabrin, DM; Solé, D, 1996) |
| "A double-blind, crossover trial was conducted to examine the effect of albuterol aerosol on the fine-motor performance of children with chronic asthma." | 9.06 | The effect of albuterol aerosol on fine-motor performance in children with chronic asthma. ( Bender, B; Figueroa-Rosario, W; Mazer, B, 1990) |
| "Our investigation supports the use of intravenous salbutamol as an alternative to aminophylline in the early stages of acute severe asthma." | 9.05 | Comparison of intravenous salbutamol (albuterol) and aminophylline in the treatment of acute asthmatic attacks. ( Greif, J; Markovitz, L; Topilsky, M, 1985) |
| "11 mg) and albuterol aerosol (two sprays, 180 mcg) were compared for efficacy of bronchodilation in 120 adolescent and young adult patients with moderate to severe asthma." | 9.05 | Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma. ( Kemp, JP; Orgel, HA; Tinkelman, DG; Webb, DR, 1985) |
| "A double-blind crossover trial was conducted in 10 asthmatic patients for comparison of fenoterol with salbutamol, in 12 other asthmatic patients for comparison of reproterol with salbutamol, and in 15 other asthmatic patients for comparison of terbutaline with salbutamol." | 9.04 | [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer]. ( Budmiger, H; Kyd, K; Scherrer, M, 1978) |
| "The bronchodilating efficacy and the degree of beta2-selectivity of rimiterol, salbutamol and isoprenaline were determined in seven asthmatic patients." | 9.04 | The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients. ( Marlin, GE; Turner, P, 1975) |
| "Albuterol overdose can lead to tachycardia, hypotension, tremor, hypokalemia, and hyperglycemia in children." | 7.72 | Hypoglycemia after albuterol overdose in a pediatric patient. ( Duman, M; Ozdemir, D; Tuncok, Y; Unal, N; Yilmaz, E, 2004) |
| "The cases of two asthmatic adolescents who overdosed on albuterol are presented." | 7.68 | Propranolol treatment of albuterol poisoning in two asthmatic patients. ( Henretig, F; Joffe, M; Ramoska, EA; Spiller, HA, 1993) |
| "To study the feasibility of using high-dose continuously aerosolized albuterol aerosol in adults, seven adult asthmatic patients were treated eight times with 0." | 7.68 | High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol. ( Hergenroeder, P; Lin, RY; Smith, AJ, 1993) |
| " Then after a further 3 wk of dosing 3 times a day of the second medication (10 patients received each medication), they were challenged once more 16 h after the last dose." | 6.66 | Comparison of tremor responses to orally administered albuterol and terbutaline. ( Druz, WS; Jenne, JW; Shaughnessy, TK; Starkey, PW; Valcarenghi, G; Yu, C, 1986) |
| " 10 micrograms of clenbuterol revealed no significant differences when compared to placebo, whereas the 20 micrograms dosage as usually administered in clinical routine demonstrated significant--but only slight--differences to placebo-baseline." | 6.66 | [Novel quantitative assessment of the tremorogenic effects of the beta 2-mimetics clenbuterol and salbutamol after oral administration]. ( Schaffler, K; Schuster, D, 1985) |
| "The induction of resting tremor showed some habituation across subchronic medication, whereas cumulative and ceiling effects of the beta 2-agonists occurred in respect to tremor during both states of active muscle contraction." | 6.66 | Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol. ( Reeh, PW; Schaffler, K, 1987) |
| " Sixty-three adolescent and adult asthmatic patients were randomized to receive at separate treatment visits single doses via a pressurized metered-dose inhaler of either placebo/hydrofluoroalkane (HFA) 134a; 100 microg, 200 microg, or 400 microg albuterol/HFA 134a; 100 microg or 200 microg albuterol/chlorofluorocarbon (CFC)." | 5.10 | A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients. ( Batty, EP; Langley, SJ; Masterson, CM; Sykes, AP; Woodcock, A, 2002) |
| "At rest salmeterol and formoterol exhibited equivalent beta 2 agonist activity with regard to decrease in serum potassium levels and increase in finger tremor, with propranolol having no effect." | 5.08 | Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol. ( Grove, A; Lipworth, BJ, 1996) |
| " The bronchodilator, cardiovascular, and tremorigenic responses following administration of salbutamol (SAL), terbutaline (TER) and fenoterol (FEN) by closed-port intermittent nebulization were compared for a period of 8 hr." | 5.08 | Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. ( Naspitz, CK; Scalabrin, DM; Solé, D, 1996) |
| "The efficacy and safety of orally administered procaterol hydrochloride, a potent beta 2-adrenergic bronchodilator, was compared with that of albuterol in an eight-center, double-blind study conducted in 223 patients with mild to moderate, reversible bronchial airway obstruction." | 5.06 | A comparison of oral procaterol and albuterol in reversible airflow obstruction. ( Beaupre, A; Boulet, LP; Brandon, ML; Busse, WW; Chervinsky, P; Mazza, J; Petty, TL; Schoenweter, W, 1988) |
| "The selectivity of single oral doses of xamoterol, 200 mg, prenalterol, 50 mg, and salbutamol, 8 mg, was compared in eight healthy male volunteers by measuring their effects on sleeping heart rate, supine heart rate, blood pressure, forearm blood flow, finger tremor, and exercise heart rate in the presence and absence of the specific beta 2-adrenoceptor antagonist ICI 118,551, 25 mg." | 5.06 | The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551. ( McCaffrey, PM; Riddell, JG; Shanks, RG, 1988) |
| "A double-blind, crossover trial was conducted to examine the effect of albuterol aerosol on the fine-motor performance of children with chronic asthma." | 5.06 | The effect of albuterol aerosol on fine-motor performance in children with chronic asthma. ( Bender, B; Figueroa-Rosario, W; Mazer, B, 1990) |
| "11 mg) and albuterol aerosol (two sprays, 180 mcg) were compared for efficacy of bronchodilation in 120 adolescent and young adult patients with moderate to severe asthma." | 5.05 | Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma. ( Kemp, JP; Orgel, HA; Tinkelman, DG; Webb, DR, 1985) |
| "Our investigation supports the use of intravenous salbutamol as an alternative to aminophylline in the early stages of acute severe asthma." | 5.05 | Comparison of intravenous salbutamol (albuterol) and aminophylline in the treatment of acute asthmatic attacks. ( Greif, J; Markovitz, L; Topilsky, M, 1985) |
| "The bronchodilating efficacy and the degree of beta2-selectivity of rimiterol, salbutamol and isoprenaline were determined in seven asthmatic patients." | 5.04 | The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients. ( Marlin, GE; Turner, P, 1975) |
| "A double-blind crossover trial was conducted in 10 asthmatic patients for comparison of fenoterol with salbutamol, in 12 other asthmatic patients for comparison of reproterol with salbutamol, and in 15 other asthmatic patients for comparison of terbutaline with salbutamol." | 5.04 | [The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer]. ( Budmiger, H; Kyd, K; Scherrer, M, 1978) |
| "Albuterol overdose can lead to tachycardia, hypotension, tremor, hypokalemia, and hyperglycemia in children." | 3.72 | Hypoglycemia after albuterol overdose in a pediatric patient. ( Duman, M; Ozdemir, D; Tuncok, Y; Unal, N; Yilmaz, E, 2004) |
| "To study the feasibility of using high-dose continuously aerosolized albuterol aerosol in adults, seven adult asthmatic patients were treated eight times with 0." | 3.68 | High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol. ( Hergenroeder, P; Lin, RY; Smith, AJ, 1993) |
| "The cases of two asthmatic adolescents who overdosed on albuterol are presented." | 3.68 | Propranolol treatment of albuterol poisoning in two asthmatic patients. ( Henretig, F; Joffe, M; Ramoska, EA; Spiller, HA, 1993) |
| "Subjects with COPD (mean FEV1 1." | 2.73 | Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. ( Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA, 2008) |
| " No significant correlations existed between change in heart rate and Cmax (r = 0." | 2.70 | Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol. ( Fowler, SJ; Lipworth, BJ, 2001) |
| " No adverse events of clinical relevance were reported." | 2.69 | Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma. ( Bondesson, E; Friberg, K; Löfdahl, CG; Soliman, S, 1998) |
| " The purpose of this study was to evaluate the dose-response effects of racemic (+/-) salbutamol and its R(-) and S(+) isomers in terms of pharmacokinetics and pharmacodynamics at extrapulmonary beta 2 adrenoceptors when given by the inhaled route to healthy volunteers." | 2.68 | Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers. ( Arbeeny, C; Clark, DJ; Koch, P; Lipworth, BJ, 1997) |
| "Thirty-five separate episodes of acute bronchial asthma were studied in 21 asthmatic children." | 2.67 | Efficacy and side effects of salbutamol in acute asthma in children: comparison of oral route and two different nebulizer systems. ( Naspitz, CK; Scalabrin, DM, 1993) |
| "For most patients with mild to moderate bronchial asthma higher doses will not add much to the bronchodilating effect." | 2.67 | A study with cumulative doses of formoterol and salbutamol in children with asthma. ( Foucard, T; Lönnerholm, G, 1991) |
| "tremor) were more frequent after treatment with 100 micrograms b." | 2.67 | Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. ( Dahl, R; Earnshaw, JS; Palmer, JB, 1991) |
| "This study investigated the effects of isamoltane on the changes induced by cumulative doses of inhaled albuterol (salbutamol) on bronchomotor tone, skeletal muscle, circulatory system, and metabolism after single (day 1) and multiple dosing (day 7) in 15 healthy subjects." | 2.67 | Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers. ( Bauer, K; Dietersdorfer, F; Kaik, G, 1993) |
| " In contrast to airways effects, systemic beta-adrenoceptor responses did not occur until 500 micrograms, and a ceiling in the dose-response curve was not reached." | 2.66 | Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. ( Lipworth, BJ; McDevitt, DG, 1989) |
| " Three hours after drug ingestion, dose-response curves were constructed using cumulative doses of inhaled salbutamol: 200 micrograms, 700 micrograms, 1700 micrograms, 3200 micrograms, 6200 micrograms." | 2.66 | Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade. ( Brown, RA; Lipworth, BJ; McDevitt, DG, 1989) |
| " The purpose of the present study was to assess the pharmacokinetics, efficacy and adverse effects of standard salbutamol tablets given by this route to patients with asthma." | 2.66 | Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. ( Clark, GA; Clark, RA; Dhillon, DP; Lipworth, BJ; McDevitt, DG; Moreland, TA; Struthers, AD, 1989) |
| "The induction of resting tremor showed some habituation across subchronic medication, whereas cumulative and ceiling effects of the beta 2-agonists occurred in respect to tremor during both states of active muscle contraction." | 2.66 | Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol. ( Reeh, PW; Schaffler, K, 1987) |
| " Then after a further 3 wk of dosing 3 times a day of the second medication (10 patients received each medication), they were challenged once more 16 h after the last dose." | 2.66 | Comparison of tremor responses to orally administered albuterol and terbutaline. ( Druz, WS; Jenne, JW; Shaughnessy, TK; Starkey, PW; Valcarenghi, G; Yu, C, 1986) |
| " 10 micrograms of clenbuterol revealed no significant differences when compared to placebo, whereas the 20 micrograms dosage as usually administered in clinical routine demonstrated significant--but only slight--differences to placebo-baseline." | 2.66 | [Novel quantitative assessment of the tremorogenic effects of the beta 2-mimetics clenbuterol and salbutamol after oral administration]. ( Schaffler, K; Schuster, D, 1985) |
| " At the end of each 14-day treatment, a dose-response curve (DRC) was performed, and airway (FEV1, FEF25-75) chronotropic (HR), tremor, and metabolic (K, Glu) responses were measured at each step (from 100 to 4,000 micrograms)." | 2.66 | Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics. ( Lipworth, BJ; McDevitt, DG; Struthers, AD, 1989) |
| "Tremor was recorded with the higher doses of albuterol." | 2.64 | Albuterol and ephedrine in patients with reversible obstructive airway disease. ( Whitsett, TL, 1977) |
| "Incidences of COPD-related adverse events were similar for active and placebo treatments." | 2.49 | The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease. ( Decramer, ML; Hanania, NA; Lötvall, JO; Yawn, BP, 2013) |
| "Life-threatening anaphylactic shock is a rare (1 in 1 million) but documented occurrence in response to subcutaneous immunotherapy." | 1.48 | Neurologic manifestations in anaphylaxis due to subcutaneous allergy immunotherapy: A case report. ( Mangold, M; Qureshi, M, 2018) |
| "Although tremor has multiple sources, it is partly central in origin, reflecting a component of motoneuron discharge at this frequency." | 1.38 | Beta-adrenergic modulation of tremor and corticomuscular coherence in humans. ( Baker, MR; Baker, SN, 2012) |
| "Tremor was measured using a laser pointer technique." | 1.32 | Tremor side effects of salbutamol, quantified by a laser pointer technique. ( Broeders, ME; Folgering, HT; Nizet, TA, 2004) |
| "A study was undertaken to test the hypothesis that airway calibre may alter lung deposition and therefore lung bioavailability of inhaled drugs as a result of narrowed airways reducing peripheral drug delivery." | 1.30 | Effects of airway calibre on lung delivery of nebulised salbutamol. ( Clark, DJ; Lipworth, BJ, 1997) |
| "Serum sex hormones, lymphocyte beta2-adrenoceptor parameters, and bronchodilator and systemic dose-response curves (DRCs) to albuterol (Salbutamol) (100 to 1,600 microg) were measured at both on and off periods." | 1.30 | Beta2-adrenoceptor regulation and function in female asthmatic patients receiving the oral combined contraceptive pill. ( Lipworth, BJ; McFarlane, LC; Tan, KS, 1998) |
| "Tremor has been found to be a limiting side effect with the oral or the inhaled forms." | 1.28 | An exaggerated response to beta-adrenergics. ( Lerner, C; Ozog, D, 1989) |
| " There was a linear log dose-response relationship for each airways parameter (FEV1, VC, sGaw, FEF 50%)." | 1.27 | Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma. ( Brown, RA; Clark, RA; Dhillon, DP; Lipworth, BJ; McDevitt, DG, 1988) |
| "Cumulative dose-response curves for orally administered fenoterol and salbutamol concerning effects of FEV1, heart rate, blood pressure and tremor were constructed." | 1.26 | Cumulative dose-response curves for comparison of oral bronchodilating drugs. A study of salbutamol and fenoterol. ( Larsson, S; Svedmyr, N, 1977) |
| " Cumulative dose-response curves for both routes of administration concerning 1-sec forced expiratory volume, forced vital capacity, heart rate, blood pressure, and tremor were constructed." | 1.26 | Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics. ( Larsson, S; Svedmyr, N, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (57.35) | 18.7374 |
| 1990's | 19 (27.94) | 18.2507 |
| 2000's | 6 (8.82) | 29.6817 |
| 2010's | 4 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mangold, M | 1 |
| Qureshi, M | 1 |
| Hostrup, M | 1 |
| Kalsen, A | 1 |
| Auchenberg, M | 1 |
| Bangsbo, J | 1 |
| Backer, V | 1 |
| Donohue, JF | 1 |
| Hanania, NA | 2 |
| Sciarappa, KA | 1 |
| Goodwin, E | 1 |
| Grogan, DR | 1 |
| Baumgartner, RA | 1 |
| Hanrahan, JP | 1 |
| Baker, MR | 1 |
| Baker, SN | 1 |
| Decramer, ML | 1 |
| Lötvall, JO | 1 |
| Yawn, BP | 1 |
| Ozdemir, D | 1 |
| Yilmaz, E | 1 |
| Duman, M | 1 |
| Unal, N | 1 |
| Tuncok, Y | 1 |
| Nizet, TA | 1 |
| Broeders, ME | 1 |
| Folgering, HT | 1 |
| Löfdahl, CG | 3 |
| Bengtsson, B | 2 |
| Svedmyr, K | 2 |
| Svedmyr, N | 7 |
| Tang, OT | 1 |
| Flatley, M | 1 |
| Andersson, P | 1 |
| Olsson, OA | 1 |
| Waldeck, B | 1 |
| Kaik, G | 2 |
| Kaik, B | 1 |
| Laggner, A | 1 |
| Berg, IM | 1 |
| Berg, T | 1 |
| Ringqvist, I | 1 |
| Wheeldon, NM | 2 |
| McDevitt, DG | 7 |
| Lipworth, BJ | 13 |
| Wang, CR | 1 |
| Yeh, TS | 1 |
| Chuang, CY | 1 |
| Chen, CY | 1 |
| Bauer, K | 1 |
| Dietersdorfer, F | 1 |
| Ramoska, EA | 1 |
| Henretig, F | 1 |
| Joffe, M | 1 |
| Spiller, HA | 1 |
| Lin, RY | 1 |
| Smith, AJ | 1 |
| Hergenroeder, P | 1 |
| Scalabrin, DM | 2 |
| Naspitz, CK | 2 |
| Grove, A | 1 |
| Solé, D | 1 |
| Clark, DJ | 3 |
| Koch, P | 1 |
| Arbeeny, C | 1 |
| Tan, KS | 1 |
| McFarlane, LC | 1 |
| Bondesson, E | 1 |
| Friberg, K | 1 |
| Soliman, S | 1 |
| Cazzola, M | 1 |
| Calderaro, F | 1 |
| Califano, C | 1 |
| Di Pema, F | 1 |
| Vinciguerra, A | 1 |
| Donner, CF | 1 |
| Matera, MG | 1 |
| Tesfamariam, B | 1 |
| Waldron, T | 1 |
| Seymour, AA | 1 |
| Taylor, DR | 1 |
| Hancox, RJ | 1 |
| McRae, W | 1 |
| Cowan, JO | 1 |
| Flannery, EM | 1 |
| McLachlan, CR | 1 |
| Herbison, GP | 1 |
| Fowler, SJ | 1 |
| Langley, SJ | 1 |
| Sykes, AP | 1 |
| Batty, EP | 1 |
| Masterson, CM | 1 |
| Woodcock, A | 1 |
| Mancini, G | 1 |
| Mannino, F | 2 |
| Pinder, RM | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Larsson, S | 4 |
| Marlin, GE | 1 |
| Turner, P | 1 |
| Whitsett, TL | 1 |
| Mariotta, S | 1 |
| Pasqua, F | 1 |
| Bennis, J | 1 |
| Budmiger, H | 1 |
| Kyd, K | 1 |
| Scherrer, M | 1 |
| Renovanz, HD | 1 |
| Nonhoff, R | 1 |
| Foucard, T | 1 |
| Lönnerholm, G | 1 |
| Dahl, R | 1 |
| Earnshaw, JS | 1 |
| Palmer, JB | 1 |
| Mazer, B | 1 |
| Figueroa-Rosario, W | 1 |
| Bender, B | 1 |
| McCaffrey, PM | 1 |
| Riddell, JG | 1 |
| Shanks, RG | 1 |
| Vathenen, AS | 1 |
| Britton, JR | 1 |
| Ebden, P | 1 |
| Cookson, JB | 1 |
| Wharrad, HJ | 1 |
| Tattersfield, AE | 1 |
| Ozog, D | 1 |
| Lerner, C | 1 |
| Brown, RA | 2 |
| Clark, RA | 2 |
| Dhillon, DP | 2 |
| Moreland, TA | 1 |
| Struthers, AD | 2 |
| Clark, GA | 1 |
| Scheinin, M | 1 |
| Koulu, M | 1 |
| Laurikainen, E | 1 |
| Allonen, H | 1 |
| Schaffler, K | 2 |
| Reeh, PW | 1 |
| Ullman, A | 1 |
| Marangio, E | 1 |
| Pesci, A | 1 |
| Mori, A | 1 |
| Marchioni, M | 1 |
| Bertorelli, G | 1 |
| Petty, TL | 1 |
| Brandon, ML | 1 |
| Busse, WW | 1 |
| Chervinsky, P | 1 |
| Schoenweter, W | 1 |
| Beaupre, A | 1 |
| Boulet, LP | 1 |
| Mazza, J | 1 |
| Jenkins, SC | 1 |
| Moxham, J | 1 |
| Jenne, JW | 1 |
| Valcarenghi, G | 1 |
| Druz, WS | 1 |
| Starkey, PW | 1 |
| Yu, C | 1 |
| Shaughnessy, TK | 1 |
| Greif, J | 1 |
| Markovitz, L | 1 |
| Topilsky, M | 1 |
| Storms, WW | 1 |
| Hudson, LD | 1 |
| DeGraff, AC | 1 |
| Mendelson, LM | 1 |
| Greenstein, S | 1 |
| Schuster, D | 1 |
| Orgel, HA | 1 |
| Kemp, JP | 1 |
| Tinkelman, DG | 1 |
| Webb, DR | 1 |
| Haukkamaa, M | 1 |
| Gummerus, M | 1 |
| Kleimola, T | 1 |
| Richens, A | 1 |
| Watson, JM | 1 |
| Kingsley, PJ | 1 |
| Volans, GN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Epinephrine Inhalation Aerosol USP, an HFA-MDI CLINICAL STUDY-B2 FOR ASSESSMENT OF PHARMACOKINETICS (A Randomized, Evaluator-Blind, Single-Dose, Two Arm, Crossover, PK Study in Healthy Volunteers)[NCT01188577] | Phase 1/Phase 2 | 23 participants (Actual) | Interventional | 2010-08-31 | Completed | ||
| CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS, A Randomized, Evaluator-Blind, Single-Dose, Three Arm, Crossover,PK Study in Healthy Volunteers[NCT01255709] | Phase 2 | 24 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)[NCT01796730] | Phase 4 | 60 participants (Actual) | Interventional | 2013-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Patient PK blood samples were taken from a vein in a hand or arm via indwelling heparin-anticoagulated IV catheters, or by venipunctures at 0 (baseline), 2, 5, 7.5, 10, 12.5, 15, 20, 25, 30, 45, 60, 90, 120, 240, and 360 minutes post-dose in each treatment period and were analyzed using an established analysis method. Area under the curve from time zero to 6 hours post-dose (AUC[0-6]) was calculated using the trapezoidal rule. (NCT01188577)
Timeframe: Pre-dose to 6 hours post-dose
| Intervention | pg*min/mL (Mean) |
|---|---|
| Treatment T | 8498 |
| Treatment C | 6191 |
Patient PK blood samples were taken from a vein in a hand or arm via indwelling heparin-anticoagulated IV catheters, or by venipunctures at Baseline (prior to dosing) in each treatment period following a specified washout period (3-14 days), and were analyzed using an established analysis method. Baseline concentration (C0) is the concentration of epinephrine measured in the plasma at this time point. (NCT01188577)
Timeframe: 0 to 30 minutes prior to dosing
| Intervention | pg/mL (Mean) |
|---|---|
| Treatment T | 2.6 |
| Treatment C | 4.3 |
Patient PK blood samples were taken from a vein in a hand or arm via indwelling heparin-anticoagulated IV catheters, or by venipunctures at 0 (baseline), 2, 5, 7.5, 10, 12.5, 15, 20, 25, 30, 45, 60, 90, 120, 240, and 360 minutes post-dose in each treatment period and were analyzed using an established analysis method. Half-life (t1/2) is the amount of time it takes for epinephrine to decrease to half the peak concentration in plasma during the treatment period. (NCT01188577)
Timeframe: Pre-dose to 6 hours post-dose
| Intervention | min (Mean) |
|---|---|
| Treatment T | 145.9 |
| Treatment C | 289.8 |
Patient PK blood samples were taken from a vein in a hand or arm via indwelling heparin-anticoagulated IV catheters, or by venipunctures at 0 (baseline), 2, 5, 7.5, 10, 12.5, 15, 20, 25, 30, 45, 60, 90, 120, 240, and 360 minutes post-dose in each treatment period and were analyzed using an established analysis method. Peak (maximum) concentration (Cmax) is the highest concentration of epinephrine measured in plasma during the treatment period. (NCT01188577)
Timeframe: Pre-dose to 6 hours post-dose
| Intervention | pg/mL (Mean) |
|---|---|
| Treatment T | 862 |
| Treatment C | 190 |
Patient PK blood samples were taken from a vein in a hand or arm via indwelling heparin-anticoagulated IV catheters, or by venipunctures at 0 (baseline), 2, 5, 7.5, 10, 12.5, 15, 20, 25, 30, 45, 60, 90, 120, 240, and 360 minutes post-dose in each treatment period and were analyzed using an established analysis method. Tmax is the amount of time it takes for epinephrine to reach peak concentration in plasma during the treatment period. (NCT01188577)
Timeframe: Pre-dose to 6 hours post-dose
| Intervention | min (Mean) |
|---|---|
| Treatment T | 2.3 |
| Treatment C | 3.4 |
Patient PK blood samples were taken from a vein in a hand or arm via indwelling heparin-anticoagulated IV catheters, or by venipunctures at 0 (baseline), 2, 5, 7.5, 10, 12.5, 15, 20, 25, 30, 45, 60, 90, 120, 240, and 360 minutes post-dose in each treatment period and were analyzed using an established analysis method. (NCT01188577)
Timeframe: Pre-dose to 6 hours post-dose
| Intervention | pg/mL (Mean) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 min (Baseline) | 2 min post-dose | 5 min post-dose | 7.5 min post-dose | 10 min post-dose | 12.5 min post-dose | 15 min post-dose | 20 min post-dose | 25 min post-dose | 30 min post-dose | 45 min post-dose | 60 min post-dose | 90 min post-dose | 120 min post-dose | 240 min post-dose | 360 min post-dose | |
| Treatment C | 4.3 | 189.0 | 99.1 | 48.8 | 39.7 | 33.9 | 32.0 | 30.1 | 20.3 | 17.7 | 19.8 | 13.2 | 11.2 | 6.9 | 17.7 | 17.2 |
| Treatment T | 2.6 | 861.5 | 379.4 | 186.6 | 118.3 | 75.6 | 46.8 | 22.9 | 10.9 | 10.5 | 10.5 | 8.7 | 3.5 | 6.5 | 16.1 | 17.1 |
3 reviews available for albuterol and Tremor
| Article | Year |
|---|---|
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Blood Glucose; Cough; Ethanolamines; Formoterol Fuma | 2013 |
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
Topics: Absorption; Administration, Oral; Aerosols; Albuterol; Animals; Asthma; Bronchodilator Agents; Catec | 1977 |
Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration.
Topics: Administration, Oral; Adrenergic beta-Agonists; Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; E | 1977 |
50 trials available for albuterol and Tremor
| Article | Year |
|---|---|
Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes.
Topics: Administration, Oral; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Analysis of Variance; A | 2016 |
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Ex | 2008 |
Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Animals; Asthma; Bronchodilator Agents; Depression | 1982 |
A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol.
Topics: Adult; Aerosols; Aged; Albuterol; Atropine Derivatives; Blood Pressure; Drug Combinations; Ethanolam | 1984 |
[Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
Topics: Aerosols; Airway Obstruction; Albuterol; Asthma; Atropine Derivatives; Drug Combinations; Ethanolami | 1980 |
Salbutamol in the treatment of asthmatic children. A comparison of oral and inhalation therapy alone and in combination.
Topics: Administration, Oral; Adolescent; Aerosols; Albuterol; Asthma; Child; Double-Blind Method; Female; F | 1982 |
Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Bisoprolol; Drug Interactions; Hem | 1994 |
The effects of lower than conventional doses of oral nadolol on relative beta 1/beta 2-adrenoceptor blockade.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists | 1994 |
Salbutamol in treatment of bronchial asthma--comparison of controlled release tablet with standard tablet.
Topics: Adult; Aged; Albuterol; Asthma; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Mal | 1993 |
Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Dose-Response Relationship, Drug; Double-Blind Method | 1993 |
Efficacy and side effects of salbutamol in acute asthma in children: comparison of oral route and two different nebulizer systems.
Topics: Acute Disease; Administration, Oral; Adolescent; Albuterol; Asthma; Blood Pressure; Child; Female; F | 1993 |
Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Bronchod | 1996 |
Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator | 1996 |
Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
Topics: Adult; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Doubl | 1997 |
Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Chlorofluorocarbons; Cross-O | 1998 |
Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Cross-Over Studies; Drug Administration Schedule; | 1998 |
Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Cross-Over Studies; Drug Administration Schedule; | 1998 |
Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Cross-Over Studies; Drug Administration Schedule; | 1998 |
Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
Topics: Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Cross-Over Studies; Drug Administration Schedule; | 1998 |
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bron | 1999 |
The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Amino Acid Sequence; Asthma; Bronchodilator Agents | 2000 |
Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Cross-Over Studies; Double-B | 2001 |
A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Albuterol; Asthma; Bronchodilato | 2002 |
Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.
Topics: Absorption; Administration, Oral; Aerosols; Albuterol; Animals; Asthma; Bronchodilator Agents; Catec | 1977 |
The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Blood Pressure; Bronchi; Bronchodilator Agents; | 1975 |
Albuterol and ephedrine in patients with reversible obstructive airway disease.
Topics: Airway Obstruction; Albuterol; Blood Pressure; Clinical Trials as Topic; Ephedrine; Forced Expirator | 1977 |
[Intravenous salbutamol in the treatment of bronchial spasm].
Topics: Aerosols; Albuterol; Arrhythmias, Cardiac; Bronchial Spasm; Clinical Trials as Topic; Drug Evaluatio | 1978 |
A controlled comparison of salbutamol and terbutaline inhaled by IPPV in asthmatic patients: a dose-response study.
Topics: Adult; Albuterol; Asthma; Bronchitis; Clinical Trials as Topic; Dose-Response Relationship, Drug; Do | 1977 |
A comparison of two modes of administering beta2-adrenoceptor stimulants in asthmatics: tablets and metered aerosol.
Topics: Administration, Oral; Aerosols; Albuterol; Asthma; Blood Pressure; Clinical Trials as Topic; Dose-Re | 1977 |
[The bronchospasmolytics salbutamol, fenoterol, terbutaline and reproterol. Their effects and side effects in asthmatics after inhalation with an electric nebulizer].
Topics: Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Female; Fenoterol; Humans; Hypoxia; Male; Met | 1978 |
[Level of lactates and examinations of tremor under Clenbuterol (NAB 365)].
Topics: Albuterol; Analysis of Variance; Aniline Compounds; Asthma; Clinical Trials as Topic; Drug Evaluatio | 1975 |
A study with cumulative doses of formoterol and salbutamol in children with asthma.
Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Child; Dose-Response | 1991 |
Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Do | 1991 |
The effect of albuterol aerosol on fine-motor performance in children with chronic asthma.
Topics: Administration, Inhalation; Adolescent; Albuterol; Asthma; Child; Child, Preschool; Double-Blind Met | 1990 |
The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Blood Pressure; Double-Blind Method; Heart Rate; Hemo | 1988 |
High-dose inhaled albuterol in severe chronic airflow limitation.
Topics: Aged; Albuterol; Cardiac Complexes, Premature; Dose-Response Relationship, Drug; Female; Forced Expi | 1988 |
Beta-adrenoceptor responses to inhaled salbutamol in normal subjects.
Topics: Administration, Inhalation; Adult; Albuterol; Blood Glucose; Blood Pressure; Dose-Response Relations | 1989 |
Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade.
Topics: Administration, Inhalation; Adrenergic beta-Antagonists; Adult; Albuterol; Dose-Response Relationshi | 1989 |
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.
Topics: Administration, Inhalation; Administration, Oral; Administration, Sublingual; Adult; Aged; Albuterol | 1989 |
Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics.
Topics: Administration, Inhalation; Adult; Albuterol; Asthma; Blood Glucose; Dose-Response Relationship, Dru | 1989 |
Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
Topics: Administration, Inhalation; Adult; Albuterol; Cyclic AMP; Dose-Response Relationship, Drug; Electroc | 1987 |
Induction and reduction of muscle tremor upon acute and repeated administration of the beta 2-agonists terbutaline, salbutamol and tulobuterol.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Electromyography; Heart Rate; Humans; Is | 1987 |
Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Blood Pressure; Clini | 1988 |
Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
Topics: Albuterol; Atropine Derivatives; Bronchodilator Agents; Clinical Trials as Topic; Drug Combinations; | 1986 |
A comparison of oral procaterol and albuterol in reversible airflow obstruction.
Topics: Administration, Oral; Airway Obstruction; Albuterol; Asthma; Bronchodilator Agents; Clinical Trials | 1988 |
High dose salbutamol in chronic bronchitis: comparison of 400 micrograms, 1 mg, 1.6 mg, 2 mg and placebo delivered by Rotahaler.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchitis; Chronic Disease; Clinical Trials as Topic; | 1987 |
Comparison of tremor responses to orally administered albuterol and terbutaline.
Topics: Administration, Oral; Aged; Albuterol; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; | 1986 |
Comparison of intravenous salbutamol (albuterol) and aminophylline in the treatment of acute asthmatic attacks.
Topics: Albuterol; Aminophylline; Asthma; Clinical Trials as Topic; Headache; Heart Rate; Humans; Injections | 1985 |
Albuterol nebulizer solution for the treatment of asthma.
Topics: Aerosols; Albuterol; Asthma; Clinical Trials as Topic; Double-Blind Method; Humans; Isoetharine; Ran | 1985 |
[Novel quantitative assessment of the tremorogenic effects of the beta 2-mimetics clenbuterol and salbutamol after oral administration].
Topics: Administration, Oral; Adult; Albuterol; Blood Pressure; Clenbuterol; Clinical Trials as Topic; Dose- | 1985 |
Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
Topics: Adolescent; Adult; Aerosols; Albuterol; Asthma; Blood Pressure; Bronchodilator Agents; Dose-Response | 1985 |
Proceedings: Effects of salbutamol and terbutaline on physiological tremor in man.
Topics: Albuterol; Bronchi; Dilatation; Fingers; Heart Rate; Humans; Muscle Contraction; Placebos; Stimulati | 1973 |
A comparison of the beta 1 and beta 2 effects of subcutaneous isoprenaline, sulbutamol and terbutaline in adult man.
Topics: Adult; Albuterol; Analysis of Variance; Bronchial Spasm; Dose-Response Relationship, Drug; Forearm; | 1974 |
16 other studies available for albuterol and Tremor
| Article | Year |
|---|---|
Neurologic manifestations in anaphylaxis due to subcutaneous allergy immunotherapy: A case report.
Topics: Albuterol; Anaphylaxis; Anti-Allergic Agents; Bronchodilator Agents; Desensitization, Immunologic; D | 2018 |
Beta-adrenergic modulation of tremor and corticomuscular coherence in humans.
Topics: Adult; Albuterol; Female; Hand Strength; Humans; Male; Motor Cortex; Muscle, Skeletal; Propranolol; | 2012 |
Hypoglycemia after albuterol overdose in a pediatric patient.
Topics: Adrenergic beta-Agonists; Albuterol; Charcoal; Child, Preschool; Diseases in Twins; Drug Overdose; F | 2004 |
Tremor side effects of salbutamol, quantified by a laser pointer technique.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Asthma; Bronchodilator Agents; Child; Child, | 2004 |
Comparison of beta 2-adrenoceptor stimulation in bronchial and skeletal muscle in experimental and clinical studies.
Topics: Albuterol; Animals; Asthma; Bronchi; Cats; Guinea Pigs; Histamine; Humans; Muscle, Smooth; Muscles; | 1984 |
Propranolol treatment of albuterol poisoning in two asthmatic patients.
Topics: Adolescent; Albuterol; Asthma; Charcoal; Drug Overdose; Female; Gastric Lavage; Humans; Hypokalemia; | 1993 |
High serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol.
Topics: Adult; Aerosols; Albuterol; Aminophylline; Asthma; Female; Forced Expiratory Volume; Heart Rate; Hum | 1993 |
Beta2-adrenoceptor regulation and function in female asthmatic patients receiving the oral combined contraceptive pill.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Area Under Curve; Asthma; Beclome | 1998 |
Effects of airway calibre on lung delivery of nebulised salbutamol.
Topics: Absorption; Administration, Inhalation; Adult; Albuterol; Asthma; Biological Availability; Bronchi; | 1997 |
Quantitation of tremor in response to beta-adrenergic receptor stimulation in primates: relationship with hypokalemia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Anesthesia; Animals; Chlorocebus a | 1998 |
[Side-effects of beta-adrenergic drugs].
Topics: Adrenergic beta-Agonists; Albuterol; Angina Pectoris; Arrhythmias, Cardiac; Headache; Humans; Hypert | 1976 |
Cumulative dose-response curves for comparison of oral bronchodilating drugs. A study of salbutamol and fenoterol.
Topics: Albuterol; Blood Pressure; Dose-Response Relationship, Drug; Ethanolamines; Female; Fenoterol; Force | 1977 |
Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics.
Topics: Adult; Aerosols; Albuterol; Asthma; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart | 1977 |
An exaggerated response to beta-adrenergics.
Topics: Adrenergic beta-Agonists; Albuterol; Child; Humans; Isoetharine; Male; Metaproterenol; Neurologic Ex | 1989 |
Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Asthma; Blood Pressure; Cyclic AMP; Dose-Respons | 1988 |
Serum salbutamol concentrations during oral and intravenous treatment in pregnant women.
Topics: Administration, Oral; Albuterol; Female; Humans; Infusions, Parenteral; Obstetric Labor, Premature; | 1985 |